publication venue for
- Synergistic effects of alcohol and HIV TAT protein on macrophage migration and neurotoxicity.. 368. 2022
- Characterization, isolation, and in vitro culture of leptomeningeal fibroblasts.. 361. 2021
- Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis.. 309. 2017
- Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.. 303. 2016
- Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.. 288. 2015
- The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.. 283. 2015
- Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.. 255. 2012
- Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.. 233. 2010
- Gene expression profiling in nerve biopsy of vasculitic neuropathy.. 225. 2010
- NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS.. 222. 2010
- TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.. 216. 2009
- Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex.. 217. 2009
- Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside.. 177. 2006
- Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis.. 171. 2005
- CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism.. 164. 2005
- Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.. 164. 2005
- Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue.. 159. 2004
- The autoimmune T and B cell repertoires in monozygotic twins discordant for myasthenia gravis.. 148. 2004
- Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni.. 146. 2004
- Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis.. 144. 2003
- Ganglioside reactive antibodies in the neuropathy associated with celiac disease.. 127. 2002
- Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.. 110. 2000
- Antibodies to chondroitin sulfates A, B, and C: clinico-pathological correlates in neurological diseases.. 108. 2000
- Antigen presenting capacity of brain microvasculature in altered peptide ligand modulation of experimental allergic encephalomyelitis.. 93. 1999
- Involvement of capsaicin sensitive primary afferents in thymulin-induced hyperalgesia.. 91. 1998
- Antibodies to chondroitin sulfate C: a new detection assay and correlations with neurological diseases.. 84. 1998
- Altered peptide ligand modulation of experimental allergic encephalomyelitis: immune responses within the CNS.. 81. 1998
- Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides.. 78. 1997
- The effect of thymectomy on autoreactive T- and B-lymphocytes in myasthenia gravis.. 74. 1997
- Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis.. 58. 1995
- IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses.. 58. 1995
- Affinity studies of human anti-MAG antibodies in neuropathy.. 52. 1994
- Somatically mutated member of the human V lambda VIII gene family encodes anti-myelin-associated glycoprotein (MAG) activity.. 51. 1994
- Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells.. 50. 1994
- Dopamine receptors on human T- and B-lymphocytes.. 45. 1993
- Human muscle acetylcholine receptor reactive T and B lymphocytes in the peripheral blood of patients with myasthenia gravis.. 42. 1993
- DNA sequence analysis and comparison of the variable heavy and light chain regions of two IgM, monoclonal, anti-myelin associated glycoprotein antibodies.. 36. 1992
- Identification of glycoconjugates which are targets for anti-Gal(beta 1-3)GalNAc autoantibodies in spinal motor neurons.. 34. 1991
- Malignant glioma modulation of immune function: relative contribution of different soluble factors.. 33. 1991
- The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation.. 31. 1991
- Molecular cloning of a human immunoglobulin heavy chain variable (vh) region with anti-myelin-associated glycoprotein activity.. 30. 1990
- Autoantigens in human neuroblastoma cells.. 26. 1990
- Molecular cloning of a human immunoglobulin heavy chain variable (VH) region with anti-myelin-associated glycoprotein activity.. 26. 1990
- Monoclonal IgMs with anti-Gal(beta 1-3) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins.. 23. 1989
- Specificity of human anti-neurofilament autoantibodies.. 21. 1989
- Localization of neural epitopes that bind to IgM monoclonal autoantibodies (M-proteins) from two patients with motor neuron disease.. 21. 1989
- Monoclonal IgM in two patients with motor neuron disease bind to the carbohydrate antigens Gal(beta 1-3)GalNAc and Gal(beta 1-3)GlcNAc.. 19. 1988
- Immune reactive C3d on the surface of myelin sheaths in neuropathy.. 18. 1988
- Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal subjects.. 17. 1988
- Characterization of oligosaccharides that bind to human anti-MAG antibodies and to the mouse monoclonal antibody HNK-1.. 12. 1986
- Glycosaminoglycan antigens in peripheral nerve. Studies with antibodies from a patient with neuropathy and monoclonal gammopathy.. 12. 1986
- Correspondence: Electroconvulsive therapy in N-methyl-D-aspartate receptor encephalitis. 2024
- Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities. 2021
- Insights into CCL21's roles in immunosurveillance and immunotherapy for gliomas. 2017
- Exploring the role of inflammation in the malignant transformation of low-grade gliomas. 2016